Natera ROE 2014-2018 | NTRA

Current and historical return on equity (ROE) values for Natera (NTRA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Natera ROE for the three months ending September 30, 2018 was -2569.52%.
Natera ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $-0.14B $0.06B -1021.43%
2018-06-30 $-0.14B $-0.02B -1944.83%
2018-03-31 $-0.14B $-0.00B -533.33%
2017-12-31 $-0.14B $0.03B -302.22%
2017-09-30 $-0.13B $0.03B -196.17%
2017-06-30 $-0.13B $0.05B -135.85%
2017-03-31 $-0.12B $0.07B -99.17%
2016-12-31 $-0.10B $0.11B -64.86%
2016-09-30 $-0.08B $0.14B -48.29%
2016-06-30 $-0.07B $0.16B -39.62%
2016-03-31 $-0.07B $0.18B -45.45%
2015-12-31 $-0.07B $0.19B -65.44%
2015-09-30 $-0.05B $0.21B -77.11%
2015-06-30 $-0.03B $0.04B -279.07%
2015-03-31 $-0.01B $0.00B inf%
2014-12-31 $-0.00B $0.00B -28.57%
Sector Industry Market Cap Revenue
Medical Medical Services $1.049B $0.211B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Express Scripts Holding (ESRX) United States $54.046B 11.17
ICON (ICLR) Ireland $7.551B 23.67
PRA Health Sciences (PRAH) United States $6.697B 27.34
Charles River Laboratories (CRL) United States $6.198B 21.73
Premier (PINC) United States $5.109B 17.34
INC Research Holdings (SYNH) United States $4.953B 19.99
HealthEquity (HQY) United States $4.266B 83.39
Teladoc (TDOC) United States $3.744B 0.00
NovoCure (NVCR) Jersey $3.128B 0.00
AMN Healthcare Services Inc (AMN) United States $2.800B 19.21
BioTelemetry (BEAT) United States $2.174B 38.41
Medpace Holdings (MEDP) United States $2.055B 25.42
Healthways (TVTY) United States $1.635B 20.10
Intrexon (XON) United States $1.243B 0.00
IKang Healthcare (KANG) China $1.233B 61.21
CareDx (CDNA) United States $1.038B 0.00
China Cord Blood (CO) China $0.729B 20.00
Surgery Partners (SGRY) United States $0.635B 0.00
Apollo Medical Holdings (AMEH) United States $0.605B 0.00
Establishment Labs Holdings (ESTA) $0.542B 0.00
Civitas Solutions (CIVI) United States $0.495B 9.75
Interpace Diagnostics (IDXG) United States $0.029B 0.00
OpGen (OPGN) United States $0.009B 0.00
Cancer Genetics (CGIX) United States $0.006B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.002B 0.00